Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms | 0.820 | 1.000 | 4 | 2009 | 2019 | |||||||
|
0.827 | 0.160 | 2 | 214807822 | intron variant | G/A;C;T | snv |
|
Neoplasms | 0.830 | 1.000 | 4 | 2009 | 2019 | ||||||||
|
0.882 | 0.080 | 2 | 214778776 | intron variant | C/T | snv | 0.16 |
|
Neoplasms | 0.810 | 1.000 | 3 | 2009 | 2019 | |||||||
|
0.827 | 0.160 | 2 | 214807822 | intron variant | G/A;C;T | snv |
|
Neoplasms; Nervous System Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||||
|
0.827 | 0.160 | 2 | 214807822 | intron variant | G/A;C;T | snv |
|
Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||||
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||||
|
1.000 | 0.040 | 2 | 214789163 | intron variant | T/A;C | snv |
|
Neoplasms | 0.800 | 1.000 | 2 | 2009 | 2012 | ||||||||
|
1.000 | 0.040 | 2 | 214762673 | intron variant | A/G | snv | 0.42 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 2 | 214754055 | intron variant | A/G | snv | 0.31 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.080 | 2 | 214778776 | intron variant | C/T | snv | 0.16 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 2 | 214778776 | intron variant | C/T | snv | 0.16 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 2 | 214751984 | intron variant | C/T | snv | 0.49 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.080 | 2 | 214780411 | intron variant | A/G | snv | 0.74 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 2 | 214780411 | intron variant | A/G | snv | 0.74 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 2 | 214780411 | intron variant | A/G | snv | 0.74 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.080 | 2 | 214771070 | intron variant | T/C | snv | 0.16 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.160 | 2 | 214807822 | intron variant | G/A;C;T | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.827 | 0.160 | 2 | 214807822 | intron variant | G/A;C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 2 | 214802180 | intron variant | T/C | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 2 | 214808716 | intron variant | T/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.040 | 2 | 214764598 | intron variant | A/G | snv | 0.41 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 2 | 214735533 | intron variant | G/A | snv | 0.34 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.200 | 2 | 214745842 | stop gained | G/A | snv | 2.4E-05 | 2.8E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.700 | 1.000 | 7 | 2012 | 2016 | ||||||
|
0.851 | 0.200 | 2 | 214745842 | stop gained | G/A | snv | 2.4E-05 | 2.8E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 6 | 2012 | 2017 |